2361 Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer. (September 2015) - Lee, S.C.; Lee, K.; Bae, S.B.; Jo Kim, Han; Oh, S.Y.; Song, S.Y.; Hong, D.S.; Jung Kim, Hyun; Yoon, J.; Lim, D.H.; Lee, S.I.; Won, J.H.; et al.